Cosmos Health reaffirms FY 2029 guidance and profit outlook
Cosmos Health reaffirms FY 2029 guidance, expecting $200.60M revenue, $71.20M gross profit, $31M net income and $44.20M adjusted EBITDA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.